Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors' returned 5 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus on Leukemias and Lymphomas   Bioseeker, Sep 2007, Pages: 500 .4 Protein Kinase Inhibitors 8.5 Vaccines 9 Cancer Indication Focus Analysis 9.1 Preclinical Stage Pipeline 9.2 Phase I Clinical Stage Pipeline 9.3 Phase II Clinical Stage Pipeline 9.4 Phase III Clinical Biomarkers - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 864 proteome analysis for early detection of cancer Triple-quadrupole MS for detection of mutant proteins Targeted MS for validation of cancer biomarkers in plasma Tissue proteomics for discovery of cancer Antibody Drug Targets and Special Focus on Leukemias & Lymphomas   Bioseeker, Dec 2007, Pages: 430 Therapeutic Effects 9.1 Anti-Angiogenesis 9.2 Apoptosis 9.3 Protein Kinase Inhibitors 10 Antibody Targets and Drugs by Cancer Indications 10.1 Basal Cell Cancer 10.2 Biliary Cancer 10.3 Bladder Cancer Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth   Datamonitor, April 2010, Pages: 243 kinases with small molecules has benefited oncology drug discovery. Efforts are continuing to develop small molecule inhibitors against other kinases that are more selective and capable of overcoming drug Antibody Drug Targets and Focus on Breast & Prostate Cancer   Bioseeker, Nov 2007, Pages: 380 signaling pathways - Cancer stem cells - Conjugated antibodies - Therapeutic effects: Anti-angiogenesis, Apoptosis and Protein Kinase Inhibition - 31 Targeted cancer indications - Availability Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network